Your browser doesn't support javascript.
loading
Metronomic Maintenance With Weekly Vinblastine After Induction With Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents Early Relapse.
Roux, Clémence; Revon-Rivière, Gabriel; Gentet, Jean Claude; Verschuur, Arnauld; Scavarda, Didier; Saultier, Paul; Appay, Romain; Padovani, Laetitia; André, Nicolas.
Afiliação
  • Roux C; Departments of Pediatric Hematology, Immunology and Oncology.
  • Revon-Rivière G; Departments of Pediatric Hematology, Immunology and Oncology.
  • Gentet JC; Departments of Pediatric Hematology, Immunology and Oncology.
  • Verschuur A; Departments of Pediatric Hematology, Immunology and Oncology.
  • Scavarda D; Metronomics Global Health Initiative.
  • Saultier P; Pediatric Neurosurgery.
  • Appay R; Departments of Pediatric Hematology, Immunology and Oncology.
  • Padovani L; C2VN, INSERM, INRAe, Aix Marseille University.
  • André N; Pathology.
J Pediatr Hematol Oncol ; 43(5): e630-e634, 2021 07 01.
Article em En | MEDLINE | ID: mdl-33235152

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vimblastina / Neoplasias Encefálicas / Bevacizumab / Irinotecano / Glioma / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Pediatr Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vimblastina / Neoplasias Encefálicas / Bevacizumab / Irinotecano / Glioma / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Pediatr Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article